William Frels - Mairs & Power
Holding/activity history for Alnylam Pharmaceuticals, Inc. (ALNY)
← All ALNY superinvestors
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2016 Q1 | 0 | 0.00 | Sell 100.00% | <0.01 | $51.51–98.00 · VW $65.77i | SEC | |
| 2015 Q4 | 2,300 | <0.01 | Buy | <0.01 | $71.14–110.75 · VW $91.30i | $217,000 | SEC |
| 2015 Q3 | 0 | 0.00 | Sell 100.00% | <0.01 | $76.46–137.89 · VW $104.89i | SEC | |
| 2015 Q2 | 2,200 | <0.01 | $120.00 | $264,000 | SEC | ||
| 2015 Q1 | 2,200 | <0.01 | $104.55 | $230,000 | SEC | ||
| 2014 Q4 | 2,200 | <0.01 | Buy | <0.01 | $72.80–111.49 · VW $93.46i | $213,000 | SEC |
Price snapshot:
Current price$288.06
52-week low$273.11
52-week high$495.55